Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study

Benjamin A. Teply, Hao Wang, Brandon Luber, Rana Sullivan, Irina Rifkind, Ashley Bruns, Avery Spitz, Morgan DeCarli, Victoria Sinibaldi, Caroline F. Pratz, Changxue Lu, John L. Silberstein, Jun Luo, Michael T. Schweizer, Charles G. Drake, Michael A. Carducci, Channing J. Paller, Emmanuel S. Antonarakis, Mario A. Eisenberger, Samuel R. Denmeade

Research output: Contribution to journalArticlepeer-review

55 Scopus citations

Fingerprint Dive into the research topics of 'Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences